Role of the neutrophil in myocardial ischemia–reperfusion injury

References

• Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190: 255–66
   PubMed Web of Science ®Google Scholar
• Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 2000; 43: 651–60
   Google Scholar
• Chatelain P, Latour JG, Tran D, de Lorgeril M, Dupras G, Bourassa M. Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation 1987; 75: 1083–90
   PubMed Web of Science ®Google Scholar
• de Lorgeril M, Rousseau G, Basmadjian A, St-Jean G, Tran DC, Latour JG. Spacial [sic.] and temporal profiles of neutrophil accumulation in the reperfused ischemic myocardium. Am J Cardiovasc Pathol 1990; 3: 143–54
   Google Scholar
• Williams FM. Neutrophils and myocardial reperfusion injury. Pharmacol Ther 1996; 72: 1–12
   Google Scholar
• Bohle RM, Klein HH, Pich S, Lindert-Heimberg S, Gehrke D, Nebendahl K. Interstitial myocardial neutrophil accumulation between 3 and 72 h of reperfusion does not significantly affect infarct size in porcine hearts. Am J Cardiovasc Pathol 1993; 4: 336–42
   Google Scholar
• Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword?. J Clin Invest 1985; 76: 17113–9
   Google Scholar
• Ebderhardt F, Melholm U, Larose K, De Vivie ER, Dhein S. Structural myocardial changes after coronary artery surgery. Eur J Clin Invest 2000; 30: 938–46
   Google Scholar
• Baxter GF. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol 2002; 97: 268–75
   PubMed Web of Science ®Google Scholar
• Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part I. Circulation 2001; 104: 2981–9
   PubMed Web of Science ®Google Scholar
• Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part II. Circulation 2001; 104: 3158–67
   PubMed Web of Science ®Google Scholar
• Park JL, Lucchesi BR. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 1999; 6: 1905–12
   Google Scholar
• Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983; 67: 1016–23
   PubMed Web of Science ®Google Scholar
• Jeroudi MO, Hartley CJ, Bolli R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol 1994; 73: 2B–7B
   PubMed Web of Science ®Google Scholar
• Pernov J, Gonon AT, Gourine A. The role of the endothelium for reperfusion injury. Eur Heart J 2001; 3: C22–7
   Google Scholar
• Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70: 181–90
   PubMed Web of Science ®Google Scholar
• Lucchesi BR. Complement, neutrophil and free radicals: mediators of reperfusion injury. Arzneimittelforschung 1994; 44: 420–32
   Google Scholar
• Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004; 61: 481–97
   PubMed Web of Science ®Google Scholar
• Chakraborti T, Mandal A, Mandal M, Das S, Chakraborti S. Complement activation in heart diseases. Role of oxidants. Cell Signal 2000; 12: 607–17
   PubMed Web of Science ®Google Scholar
• Tarnok A, Hambsch J, Emmrich F, Sack U, Son J, Bellinghausen W, et al. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass. Pediatr Cardiol 1999; 20: 113–25
   PubMedGoogle Scholar
• Kotani T, Kotake Y, Morisaki H, Takeda J, Shimizu H, Ueda T, et al. Activation of a neutrophil-derived inflammatory response in the airways during cardiopulmonary bypass. Anesth Analg 2006; 103: 1394–9
   Google Scholar
• de Oliveira-Marques V, Cyrne L, Marinho HS, Antunes F. A quantitative study of NF-kappa B activation by H2O2: relevance in inflammation and synergy with TNF-alpha. J Immunol 2007; 178: 3893–902
   PubMed Web of Science ®Google Scholar
• Sawa Y, Ichikawa H, Kagisaki K, Ohata T, Matsuda H. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg 1998; 116: 511–7
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang LM, Chaiswing L, Yen HC, Oberley TD, Lien YC, et al. Tamoxifen protects against acute tumor necrosis factor alpha-induced cardiac injury via improving mitochondrial functions. Free Radic Biol Med 2006; 40: 1234–41
   PubMed Web of Science ®Google Scholar
• Penicka M, Gregor P, Krupicka J, Jira M. Tumour necrosis factor-alpha soluble receptors type I are related to symptoms and left ventricular function in hypertrophic cardiomyopathy. Can J Cardiol 2001; 17: 777–84
   Google Scholar
• Dorge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, et al. Coronary microembolization: the role of TNF-α in contractile dysfunction. J Moll Cell Cardiol 2002; 34: 51–62
   PubMed Web of Science ®Google Scholar
• Sbrana S, Bevilacqua S, Buffa M, Spiller D, Parri MS, Gianetti J, et al. Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation. Cytometry B Clin Cytom 2005; 65: 14–21
   Google Scholar
• Auchampach JA, Pieper GM, Cavero I, Gross GJ. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function. Basic Res Cardiol 1998; 93: 361–71
   Google Scholar
• Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost 2007; 97: 738–47
   PubMed Web of Science ®Google Scholar
• Jensen RH, Stoorgaard M, Vedelsdal R, Obel N. Impaired neutrophil chemotaxis after cardiac surgery. Scand J Thorac Cardiovasc Surg 1995; 29: 115–8
   Web of Science ®Google Scholar
• Brix-Christensen V, Petersen TK, Ravn HB, Hjordtal VE, Andersen NT, Tonnesen E. Cardiopulmonary bypass elicits a pro- and anti-inflammatory cytokine response and impaired neutrophil chemotaxis in neonatal pigs. Acta Anaesthesiol Scand 2001; 45: 407–13
   PubMed Web of Science ®Google Scholar
• Gessler P, Pretre R, Hohl V, Rousson V, Fischer J, Dahinden C. CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery. Shock 2004; 22: 513–20
   Google Scholar
• Mazzone A, Ricevuti G. Leukocyte CD11/CD18 integrins: biological and clinical relevance. Haematologica 1995; 80: 161–75
   PubMed Web of Science ®Google Scholar
• Harlan, JM, Winn, RK. Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit Care Med 2002;30(Suppl)s214–9.
   Google Scholar
• Hogg N, Bates PA, Harvey J. Structure and function of intercellular adhesion molecule-1. Chem Immunol 1991; 50: 98–115
   PubMedGoogle Scholar
• Lefer AM. Role of selectins in myocardial ischemia-reperfusion injury. Ann Thorac Surg 1995; 60: 773–7
   Google Scholar
• Elliott MJ, Finn AHR. Interaction between neutrophils and the endothelium. Ann Thorac Surg 1993; 56: 1503–8
   Google Scholar
• Chen YF, Tsai WC, Lin CC, Tsai LY, Lee CS, Huang CH, et al. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg 2004; 78: 634–42
   PubMed Web of Science ®Google Scholar
• Lefer AM. Role of the beta-2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion. Ann Thorac Surg 1999; 68: 1920–3
   Google Scholar
• Schulze CJ, Wang W, Suarez-Pinzon WL, Sawicka J, Sawicki G, Schulz R. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury. Circulation 2003; 107: 2487–92
   PubMed Web of Science ®Google Scholar
• Eberl T, Amberger A, Herold M, Hengster P, Steurer W, Hochleitner BW, et al. Expression of stress proteins, adhesion molecules, and interleukin-8 in endothelial cells after preservation and reoxygenation. Cryobiology 1999; 38: 106–18
   Google Scholar
• Zimmerman GA, McIntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol 1990; 110: 529–40
   PubMed Web of Science ®Google Scholar
• Tanita T, Song C, Kubo H, Hoshikawa Y, Chida M, Suzuki S, et al. Superoxide anion mediates pulmonary vascular permeability caused by neutrophils in cardiopulmonary bypass. Surg Today 1999; 29: 755–61
   Google Scholar
• Rothenburger M, Trosch F, Markewitz A, Berendes E, Schmid C, Scheld H, et al. Leukocyte activation and phagocytotic activity in cardiac surgery and infection. Cardiovasc Surg 2002; 10: 470–5
   Google Scholar
• Pasnik J, Siniewicz K, Moll JA, Moll J, Baj Z, Sysa A, et al. Effect of cardiopulmonary bypass on neutrophil activity in pediatric open-heart surgery. Arch Immunol Ther Exp 2005; 53: 272–7
   Google Scholar
• Hubert K, Krotz-Fahning M, Hock B. Respiratory burst as a biomarker for stress responses. Protoplasma 2006; 229: 221–4
   Google Scholar
• Partrick DA, Moore EE, Fullerton DA, Barnett CCJ, Meldrum DR, Silliman CC. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res 1999; 86: 42–9
   PubMed Web of Science ®Google Scholar
• Pasnik J, Baj Z, Moll JA, Moll J, Moll M, Pokoca L, et al. Effects of cardiopulmonary bypass on the expression of adhesive molecules in children undergoing cardiac surgery due to congenital heart disorders. Kardiol Pol 2004; 60: 123–31
   Google Scholar
• Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004; 61: 461–70
   PubMed Web of Science ®Google Scholar
• Besse S, Bulteau AL, Boucher F, Riou F, Swynghedauw B, de Leiris J. Antioxidant treatment prevents cardiac protein oxidation after ischemia-reperfusion and improves myocardial function and coronary perfusion in senescent hearts. J Physiol Pharmacol 2006; 57: 541–52
   Google Scholar
• Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007; 9: 49–89
   PubMed Web of Science ®Google Scholar
• Kurzelewski M, Czarnowska E, Beresewicz A. Superoxide- and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. J Physiol Pharmacol 2005; 56: 163–78
   PubMed Web of Science ®Google Scholar
• Kohtani T, Abe Y, Sato M, Miyauchi K, Kawachi K. Protective effects of anti-neutrophil antibody against myocardial ischemia/reperfusion injury in rats. Eur Surg Res 2002; 34: 313–20
   Google Scholar
• Gando S, Tedo I. Increased neutrophil elastase release in patients with cardiopulmonary arrest: role of elastase inhibitor. Intensive Care Med 1995; 21: 636–40
   PubMed Web of Science ®Google Scholar
• Farah B, Vuillemenot A, Lecompte T, Bara L, Pasquier C, Jebara V, et al. Myocardial neutrophil sequestration and activation related to the reperfusion on human heart during coronary artery surgery. Cardiovasc Res 1994; 28: 1226–30
   PubMed Web of Science ®Google Scholar
• Laude K, Richard V, Thuillez C. Coronary endothelial cells: a target of ischemia reperfusion and its treatment?. Arch Mal Coeur Vaiss 2004; 97: 250–4
   Google Scholar
• Yanga Q, Yima AP, He GW. The significance of endothelium-derived hyperpolarizing factor in the human circulation. Curr Vasc Pharmacol 2007; 5: 85–92
   Google Scholar
• Nicolls MR, Haskins K, Flores SC. Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal 2007; 9: 879–89
   PubMed Web of Science ®Google Scholar
• Lefer AM, Campbell B, Shin YK. Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion. J Mol Cell Cardiol 1998; 30: 2561–6
   PubMed Web of Science ®Google Scholar
• Birnbaum Y, Ye Y, Rosanio S, Tavackoli S, Hu ZY, Schwarz ER, et al. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res 2005; 65: 345–55
   Google Scholar
• Cernacek P, Stewart DJ, Monge JC, Rouleau JL. The endothelin system and its role in acute myocardial infarction. Can J Physiol Pharmacol 2003; 81: 598–606
   PubMed Web of Science ®Google Scholar
• Asano G, Takashi E, Ishiwata T, Onda M, Yokoyama M, Naito Z, et al. Pathogenesis and protection of ischemia and reperfusion injury in myocardium. J Nippon Med Sch 2003; 70: 384–92
   PubMedGoogle Scholar
• Lefer AM, Tsao PS, Lefer DJ, Ma XL. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991; 5: 2029–34
   PubMed Web of Science ®Google Scholar
• Saini HK, Machackova J, Dhalla NS. Role of reactive oxygen species in ischemic preconditioning of subcellular organelles in the heart. Antioxid Redox Signal 2004; 6: 393–404
   Google Scholar
• Lefer AM, Lefer DJ. Is microcirculation important in reperfusion in man. Dial Cardiovasc Med 1998; 65: 1751–62
   Google Scholar
• Turkoz R, Yorukoglu K, Akcay A, Yilik L, Baltalarli A, Karahan N, et al. The effect of pentoxifylline on the lung during cardiopulmonary bypass. Eur J Cardiothorac Surg 1996; 10: 339–46
   Google Scholar
• Hill GE, Pohorecki R, Alonso A, Rennard SI, Robbins RA. Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass. Anesth Analg 1996; 83: 696–700
   PubMed Web of Science ®Google Scholar
• Karaca P, Konuralp C, Enc Y, Suzer A, Sokullu O, Avoglu U, et al. Cardioprotective effect of aprotinin on myocardial ischemia/reperfusion injury during cardiopulmonary bypass. Circ J 2006; 70: 1432–6
   Google Scholar
• Oostingh GJ, Pozgajova M, Ludwig RJ, Krahn T, Boehncke WH, Nieswandt B, et al. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions. Haematologica 2007; 92: 502–12
   PubMed Web of Science ®Google Scholar
• Lefer DJ, Flynn DM, Buda AJ. Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 1996; 270: H88–98
   PubMed Web of Science ®Google Scholar
• Murry CE, Jenings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 75: 1124–36
   Google Scholar
• Youker KA, Beirne J, Lee J, Michael LH, Smith CW, Entman ML. Time dependent loss of Mac-1 from infiltrating neutrophils in the reperfused myocardium. J Immunol 2000; 164: 2752–8
   Google Scholar
• Fukushima, S, Coppen, SR, Varela-Carver, A, Yamahara, K, Sarathchandra, P, Smolenski, RT, , et al. A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route. Circulation 2006;114(Suppl)I251–6
   Google Scholar
• Simpson PJ, Todd RF, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988; 81: 624–9
   PubMed Web of Science ®Google Scholar
• Simpson PJ, Todd RF, Mickelson JK, Fantone JC, Gallagher KP, Lee KA, et al. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation 1990; 81: 226–37
   PubMedGoogle Scholar
• Garner JR, Stroud RE, Finklea L, Ikonomidis JS, Dorman BH, Spinale FG. The effects of leukocyte reduction on matrix metalloproteinase release in cardiopulmonary bypass. J Extra Corpor Technol 2004; 36: 185–90
   Google Scholar
• Ilmakunnas M, Pesonen EJ, Ahonen J, Ramo J, Siitonen S, Repo H. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 130: 952–3
   Google Scholar
• Johnell M, Elgue G, Thelin S, Larsson R, Siegbahn A. Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline Heparin Surface. Scand Cardiovasc J 2002; 36: 351–7
   PubMed Web of Science ®Google Scholar
• Ueyama K, Nishimura K, Nishina T, Nakamura T, Ikeda T, Komeda M. PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery. ASAIO J 2004; 50: 369–72
   PubMed Web of Science ®Google Scholar
• Duda M, Czarnowska E, Kurzelewski M, Konior A, Beresewicz A. Ischemic preconditioning prevents endothelial dysfunction, P-selectin expression, and neutrophil adhesion by preventing endothelin and O2-generation in the post-ischemic guinea-pig heart. Physiol Pharmacol 2006; 57: 553–69
   Google Scholar
• Teoh LK, Grant R, Hulf JA, Pugsley WB, Yellon DM. The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res 2002; 53: 175–80
   PubMed Web of Science ®Google Scholar
• Vinten-Johansen J, Thourani VH, Ronson RS, Jordan JE, Zhao ZQ, Nakamura M, et al. Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 1999; 68: 1942–8
   Google Scholar
• Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4 + T lymphocytes. Circulation 2006; 114: 2056–64
   PubMed Web of Science ®Google Scholar
• Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol 1999; 34: 1711–20
   PubMed Web of Science ®Google Scholar
• Ross, AM, Gibbons, RJ, Stone, GW, Kloner, RA, Alexander, RW, AMISTAD-II Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005;45:1775–80.
   PubMed Web of Science ®Google Scholar